Neurochemical Analysis of Chronic Pain Mechanisms

Chronic pain arises from sustained alterations in neurochemical signalling within the central nervous system. Studies employing proton magnetic resonance spectroscopy have identified dysregulation of key metabolites—principally the excitatory neurotransmitter glutamate and the inhibitory transmitter γ-aminobutyric acid—in pain-processing regions such as the anterior cingulate cortex, insula, thalamus and primary somatosensory cortex. Reductions in N-acetylaspartate (a neuronal viability marker) and shifts in glial-derived myo-inositol further reflect structural and metabolic changes underpinning pain chronification. These neurochemical imbalances contribute to central sensitisation, whereby repetitive noxious input lowers activation thresholds and potentiates neural networks responsible for pain perception. By discerning region-specific metabolite profiles, researchers aim to establish non-invasive biomarkers for diagnosis, monitor treatment responses and guide the development of targeted therapies that restore excitatory–inhibitory homeostasis.

Research from Nature Portfolio

Functional magnetic resonance spectroscopy has been applied to the anterior cingulate cortex during controlled noxious stimulation to capture dynamic neurochemical responses. Investigators observed a transient surge in glutamate and combined glutamate–glutamine (Glx) concentrations at the onset of pain, with effect sizes differing between female and male participants. These findings support a role for rapid excitatory signalling in stimulus detection and highlight the potential of real-time metabolite measures to unravel pain mechanisms.

Neurochemical Analysis of Chronic Pain Mechanisms publication trend

The graph below shows the total number of articles in neurochemical analysis of chronic pain mechanisms across all publications each year (not limited to Nature Index journals).

Technical terms

N-acetylaspartate (NAA): A marker of neuronal integrity and viability measured by MRS.
Glutamate: The principal excitatory neurotransmitter in the brain, central to synaptic transmission and plasticity.
γ-Aminobutyric acid (GABA): The main inhibitory neurotransmitter that counterbalances excitatory signalling.
Functional magnetic resonance spectroscopy (fMRS): An imaging technique that quantifies real-time changes in brain metabolite levels during specific tasks or stimuli.
Glx: The combined magnetic resonance signal of glutamate and glutamine used to assess excitatory metabolism.

References

1. Altered thalamic neurotransmitters metabolism and functional connectivity during the development of chronic constriction injury induced neuropathic pain. Biological Research (2020).
2. Metabolite activity in the anterior cingulate cortex during a painful stimulus using functional MRS. Scientific Reports (2020).
3. Elevated posterior insula glutamate in patients with sickle cell disease. Journal of Pain (2024).
4. Alterações em marcadores neurometabólitos após tratamento manipulativo osteopático em indivíduos com lombalgia crônica inespecífica: revisão sistemática de ensaios clínicos randomizados. Revista Perspectiva (2023).